tiprankstipranks
Cybin Supports FDA’s Push for Psychedelic Research
PremiumCompany AnnouncementsCybin Supports FDA’s Push for Psychedelic Research
21d ago
VA secretary wants to find answers on psychedelics therapies, Politico says
Premium
The Fly
VA secretary wants to find answers on psychedelics therapies, Politico says
26d ago
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
Premium
The Fly
Psychedelic: Atai, Enveric, Incannex and Relmada report quarterly results
26d ago
Cybin announces USPTO patent in support of CYB003 program
PremiumThe FlyCybin announces USPTO patent in support of CYB003 program
1M ago
Cybin Secures New U.S. Patent for CYB003 Program in Major Depressive Disorder
Premium
Company Announcements
Cybin Secures New U.S. Patent for CYB003 Program in Major Depressive Disorder
1M ago
Cybin CEO to Speak at Milken Institute Global Conference on Medical Breakthroughs
Premium
Company Announcements
Cybin CEO to Speak at Milken Institute Global Conference on Medical Breakthroughs
1M ago
Psychedelic: Exclusive talk with retreat provider ONE Retreats
PremiumThe FlyPsychedelic: Exclusive talk with retreat provider ONE Retreats
3M ago
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
Premium
The Fly
Psychedelic: Exclusive talk with biotech company Clearmind Medicine
3M ago
Psychedelic: atai Life Sciences, NRx report quarterly results
Premium
The Fly
Psychedelic: atai Life Sciences, NRx report quarterly results
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100